Affiliations: [a] Trauma Research Group, School of Medicine and Dentistry, Queen's University Belfast, Belfast, N. Ireland, UK | [b] Medical Polymers Research Institute, School of Aeronautical and Mechanical Engineering, Queen's University Belfast, Belfast, N. Ireland, UK | Royal College of Surgeons in Ireland & Trinity College, Dublin, Ireland
Correspondence:
[*]
Address for correspondence: Glenn Dickson, Head of Tissue Engineering Research Team, Trauma Research Group, Department of Trauma and Orthopaedic Surgery, Queen's University Belfast, Musgrave Park Hospital, Stockman's Lane, Belfast BT9 7JB, N. Ireland, UK. Tel.: +44 (0)2890902858; Fax: +44 (0) 28 90661112; E-mail: [email protected].
Abstract: Orthopaedic tissue engineering combines the application of scaffold materials, cells and the release of growth factors. It has been described as the science of persuading the body to reconstitute or repair tissues that have failed to regenerate or heal spontaneously. In the case of bone regeneration 3-D scaffolds are used as a framework to guide tissue regeneration. Mesenchymal cells obtained from the patient via biopsy are grown on biomaterials in vitro and then implanted at a desired site in the patient's body. Medical implants that encourage natural tissue regeneration are generally considered more desirable than metallic implants that may need to be removed by subsequent intervention. Numerous polymeric materials, from natural and artificial sources, are under investigation as substitutes for skeletal elements such as cartilage and bone. For bone regeneration, cells (obtained mainly from bone marrow aspirate or as primary cell outgrowths from bone biopsies) can be combined with biodegradable polymeric materials and/or ceramics and absorbed growth factors so that osteoinduction is facilitated together with osteoconduction; through the creation of bioactive rather than bioinert scaffold constructs. Relatively rapid biodegradation enables advantageous filling with natural tissue while loss of polymer strength before mass is disadvantageous. Innovative solutions are required to address this and other issues such as the biocompatibility of material surfaces and the use of appropriate scaffold topography and porosity to influence bone cell gene expression.
